Awardee OrganizationUNIVERSITY OF ALABAMA AT BIRMINGHAM
Description
Abstract Text
The Administrative/Clinical Trials Core (Core A) is responsible for the administrative support of all DAB
Breast SPORE Projects, Cores and Programs, including planning and monitoring of scientific activities,
providing scientific direction, ensuring a translational research emphasis, and integrating the Projects,
Cores and Programs, including collaborations with other Breast SPORES.The Administrative/Clinical Trials
Core provides fiscal oversight including 1) employment of key personnel to ensure cost effective and
efficient use of resources and 2) utilization of SPORE flexibility to reallocate funds depending on the degree
to which the individual Projects and Cores of the UAB Breast SPORE are successful in meeting their
performance benchmarks, which allows the Administrative/Clinical Trials Core to take advantage of new
scientific opportunities as well as to remedy deficiencies. The Administrative/Clinical Trials Core provides a
vital link between investigators and the UAB Breast SPORE internal and external advisors, as well as NCI
program staff, and assumes responsibility for the preparation of all required reports and assurances.
An important component of the Administrative/Clinical Trials Core is its oversight of UAB Breast SPORE
human clinical trials, which provides for enhanced interactions between the UAB Breast SPORE and the
UAB Comprehensive Cancer Center (UABCCC). In regards to the conduct of UAB Breast SPORE human
clinical trials, the goals of the Administrative/Clinical Trials Core are to: 1) provide optimal support for
human clinical trials; 2) provide patients access to interventions/therapies developed by UAB Breast
SPORE investigators; 3) enhance interactions between UAB Breast SPORE basic and clinical
investigators; and 4) provide for enhancement and coordination of the resources available through the
UABCCC Clinical Trials Shared Facility for utilization by UAB Breast SPORE investigators. Currently, the
Breast SPORE has 12 clinical trials generated by SPORE projects, developmental projects or inter-SPORE
collaborations.
The Administrative/Clinical Trials Core also manages a registered UAB Breast SPORE website and
contributes to the Cancer Center Magazine, which serves the UAB community and the friends and
supporters of the UABCCC.
The Administrative/Clinical Trials Core supports all of the SPORE Projects with planning, monitoring and
the achievement of the scientific objectives of each SPORE Project/Core facility.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
90Y-DOTA-BiotinAccountingAchievementActivation DateAddressAdenocarcinomaAdenovirus VectorAdenovirusesAdjuvantAdministrative PersonnelAdministratorAdvertisementsAdvisory CommitteesAdvocacyAdvocateAfricanAfrican AmericanAgeAlabamaAmendmentAmericanAmerican Association of Cancer ResearchAmerican Cancer SocietyAmerican College of SurgeonsAmerican College of Surgeons Oncology GroupAmerican Society of Clinical OncologyAnimal ExperimentsAnimal ModelAntibodiesApoptosisAppendixApplications GrantsAppointmentAreaArtsAspirate substanceAtlasesAtypiaAvastinAwardAwarenessBackBaltimoreBasic ScienceBehavioral ResearchBeliefBenchmarkingBenignBibliographyBiochemistryBiodistributionBioinformaticsBiologicalBiological AssayBiological MarkersBiologyBiomedical ResearchBiometryBloodBlood specimenBone Marrow NeoplasmsBostonBrainBreastBreast Cancer CellBreast Cancer DetectionBreast Cancer PreventionBreast CarcinomaBreast DiseasesBreast FeedingBudgetsBusinessesCancer CenterCancer Center Support GrantCancer PatientCancer SurvivorCancer Therapy Evaluation ProgramCancer and Leukemia Group BCancer cell lineCapecitabine/PaclitaxelCarboplatinCaringCategoriesCell Cycle CheckpointCell surfaceCellsCellular MorphologyCellular biologyCenter Core GrantsCenters of Research ExcellenceCetuximabChairpersonCharacteristicsChemopreventionChemopreventive AgentChemotherapy-Oncologic ProcedureChildChimeric ProteinsCitiesClassificationClinicClinicalClinical ChemopreventionClinical DataClinical InvestigatorClinical ProtocolsClinical ResearchClinical TrialsClinical trial protocol documentClosureCollaborationsCollectionCombined Modality TherapyCommitCommunicationCommunitiesCommunity HealthComplexComprehensionComprehensive Cancer CenterComputer softwareComputersConduct Clinical TrialsConfidentiality of Patient InformationConflict of InterestConsent FormsConsultationsConsumer Advocates in Research and Related ActivitiesControlled StudyCore FacilityCounselingCountyCritiquesCyclic AMPCyclophosphamideCytologyCytotoxic T-LymphocytesDOTA-biotinDailyDana-Farber Cancer InstituteDataData AnalysesData CollectionDatabasesDecision MakingDependovirusDepthDevelopmentDevicesDiagnosisDirect CostsDisciplineDiseaseDisease ProgressionDisease remissionDisease-Free SurvivalDisorder by SiteDoctor of MedicineDoctor of PhilosophyDoseDose-LimitingDoxorubicinDrug KineticsDrug resistanceDuctalEGF geneERBB2 geneEastern Cooperative Oncology GroupEducationEducational CurriculumEducational MaterialsEducational workshopEligibility DeterminationEmotional StressEmploymentEnrollmentEnsureEnvironmentEpidemiologyEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEpithelial CellsEpitheliumEquilibriumEquipmentErlotinibEstradiolEstrogen AntagonistsEstrogen receptor positiveEstrogensEvaluationExcisionExpenditureFacultyFamilyFeedbackFellowshipFloridaFoundationsFrequenciesFriendsFunctional disorderFundingFunding AgencyFutureG-Protein-Coupled ReceptorsGTP-Binding ProteinsGastrointestinal tract structureGenderGene ExpressionGeneral PracticesGenerationsGenesGeneticGenisteinGoalsGovernmentGrantGranulocyte-Macrophage Colony-Stimulating FactorGuanosine MonophosphateGuidelinesHeadHealthHealth Insurance Portability and Accountability ActHealth PersonnelHealth ServicesHematologyHeparin BindingHigh Risk WomanHistologicHormonalHormonal ChangeHormone ReceptorHormonesHourHoward Temin AwardHumanHuman BiologyHuman ResourcesImageImaging TechniquesImmuneImmune responseImmunologyImmunotherapyIn SituIncidenceIndividualIndustryIndustry CollaboratorsInfantInformation SystemsInformed ConsentInstitutesInstitutionIntellectual PropertyInternal MedicineInterventionIntervention TrialInterviewIntestinal CancerIntravenousInvasiveInvestigationIowaIrrigationJournalsK-Series Research Career ProgramsKansasKnowledgeLabelLaboratoriesLaboratory ResearchLanguageLasersLeadershipLeftLetrozoleLettersLifeLinkLiquid substanceLobular CarcinomaLocal Area NetworksLocalizedLondonLos AngelesLouisianaMagnetic Resonance ImagingMailsMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of pancreasMammary Gland ParenchymaMammographyManagement AuditManuscriptsMarrowMaximum Tolerated DoseMeasurementMeasuresMediatingMedicalMedical OncologistMedical OncologyMedical centerMedicineMemorial Sloan-Kettering Cancer CenterMenopauseMentorsMentorshipMeta-AnalysisMetabolicMethodologyMethodsMethylationMichiganMicrodissectionMinorityMissionMolecularMolecular GeneticsMolecular ProfilingMolecular and Cellular BiologyMonitorMonitoring Clinical TrialsMonoclonal AntibodiesMonoclonal Antibody CC49MusNCI Director's Consumer Liaison GroupNamesNational Cancer Advisory BoardNational Cancer InstituteNational Surgical Adjuvant Breast and Bowel ProjectNatureNeedlesNeoadjuvant TherapyNeoplasm MetastasisNetwork-basedNew YorkNewly DiagnosedNipplesNormal tissue morphologyNorth CarolinaNotificationNuclearNumbersNursesNursing ResearchNutritionalOncogenesOnline SystemsOperative Surgical ProceduresOutcomeOvaryPCNA genePaclitaxelPancreasParticipantPathologicPathologyPathway interactionsPatient CarePatient EducationPatient RecruitmentsPatient advocacyPatient currently pregnantPatientsPatternPeer ReviewPeer Review GrantsPerformancePersonal ComputersPersonal SatisfactionPersonnel RecruitmentsPersonsPharmacistsPharmacologic SubstancePharmacy facilityPhasePhase I Clinical TrialsPhase I/II TrialPhase II Clinical TrialsPhase III Clinical TrialsPhenotypePhiladelphiaPhysical ExaminationPhysician ExecutivesPhysiciansPhysiologyPlasmaPlasmid Cloning VectorPliabilityPoliciesPolynucleotide VaccinesPopulationPopulations at RiskPositioning AttributePositron-Emission TomographyPostmenopausePreparationPreventionPrevention ResearchPrevention interventionPrincipal InvestigatorPrior ChemotherapyProblem SolvingProceduresProcessProductionProductivityProfessional counselorProgram DescriptionProgram DevelopmentProgress ReportsProliferative IndexProtein OverexpressionProtein SubunitsProteinsProto-Oncogene Proteins c-aktProtocols documentationPublic Health SchoolsPublicationsPublishingPurposePyrroloiminoquinonesQualifyingQuality ControlRadiationRadioactiveRadioimmunotherapyRadioisotopesRadiolabeledRadiology SpecialtyRateReagentRecommendationRecording of previous eventsRecordsRecoveryRecruitment ActivityRegistered nurseRegistriesRegulationReportingReproducibilityReproduction sporesResearchResearch ActivityResearch DesignResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch PriorityResearch Project GrantsResearch SupportResearch TrainingResidual TumorsResistanceResource AllocationResourcesRetinoidsReview CommitteeRightsRiskRoleRural PopulationSafetySamplingScheduleSchoolsScienceScientific EvaluationScientistScoreScreening procedureSelective Estrogen Receptor ModulatorsSeminalSenior ScientistSerumServicesShockSignal PathwaySignal TransductionSiteSlideSocietiesSolidSourceSouthwest Oncology GroupSpecificitySpecimenSpeedStagingStrategic PlanningStreptavidinStructureStudy SectionStudy SubjectSuggestionSupervisionSupport GroupsSurgeonSurgical OncologistSurgical OncologySurgical PathologySurrogate EndpointSurrogate MarkersSurvivorsSusan G Komen Breast Cancer FoundationSystemT-LymphocyteTAG-72 AntigenTNF receptor-associated factor 4TNFRSF5 geneTP53 geneTRAF4 geneTamoxifenTechniquesTechnologyTeleconferencesTerminologyTestingTextTherapeuticTherapeutic AgentsTherapeutic InterventionTimeTimeLineTissue BanksTissue ProcurementsTissue SampleTissuesTitleTodayToxic effectToxinTrainingTraining ProgramsTransactivationTransfectionTransgenic OrganismsTranslational ResearchTranslationsTraumaTreatment ProtocolsTrustTumor ImmunityTumorigenicityTyrosine Kinase InhibitorUltrasonographyUnderserved PopulationUnited StatesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesUniversity HospitalsUniversity of Alabama at Birmingham Cancer CenterUpdateVaccine TherapyVaccinesVascular Endothelial Growth FactorsVirginiaVisitWeekWomanWomen's GroupWomen's HealthWorkWritingabstractingangiogenesisantibody conjugateanticancer researchbasebevacizumabbreast cancer diagnosisbreast surgerycancer carecancer diagnosiscancer preventioncancer research center directorcancer therapycarcinogenesiscareercaucasian Americanchemotherapycollegecommunity organizationscomputer networkconditionally replicative adenoviruscooperative studycost effectivedata acquisitiondata managementdaydeath receptor-4designdesiredosimetrydriving forceductal breast carcinomaexperiencefeedingfight againstfightingfollow-upgastrointestinalgene therapyhormone therapyhuman TNFRSF10A proteinhuman subjectimmune functionimmunogenicityimmunopathologyimprovedinjuredinnovationinterestintravenous administrationinvestigator trainingmalignant breast neoplasmmedical schoolsmedically underserved populationmembermenminority healthminority subjectsmortalitymouse modelmullerian-inhibiting hormonemultidisciplinarymutantneoplastic cellnovelnovel therapeuticsoncologyorganizational structureoutcome forecastoutreach programpatient safetypeerpilot trialpost-doctoral trainingpre-clinicalpreclinical studyprenatalprofessorprognosticprogramspromoterprotein expressionprotocol developmentpsychologicquality assuranceracial and ethnicradiotracerreceptorresearch clinical testingresearch studyresistance mechanismresponserestorationsmoothened signaling pathwaysocioeconomicsstatisticssuccesssurvivinsymposiumtherapeutic targettime intervaltissue resourcetooltranslational studytumortumor growthtumor progressionvectorvector vaccinevolunteer
No Sub Projects information available for 2P50CA089019-06A2 9004
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P50CA089019-06A2 9004
Patents
No Patents information available for 2P50CA089019-06A2 9004
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P50CA089019-06A2 9004
Clinical Studies
No Clinical Studies information available for 2P50CA089019-06A2 9004
News and More
Related News Releases
No news release information available for 2P50CA089019-06A2 9004
History
No Historical information available for 2P50CA089019-06A2 9004
Similar Projects
No Similar Projects information available for 2P50CA089019-06A2 9004